Eastern Mediterranean (WHO region) vs Sao Tome and Principe: Treatment success rate for patients treated for MDR-TB

Eastern Mediterranean (WHO region)
75.0%
in 2022
Sao Tome and Principe
100.0%
in 2022
Eastern Mediterranean (WHO region) rank
4th
Sao Tome and Principe rank
1st

Treatment success rate for patients treated for MDR-TB over time

  • Eastern Mediterranean (WHO region)
  • Sao Tome and Principe
020406080100200220122022

How they compare

Sao Tome and Principe currently reports 100.0% against 75.0% in Eastern Mediterranean (WHO region), a difference of 25.0%.

That makes Sao Tome and Principe's figure about 1.3 times Eastern Mediterranean (WHO region)'s.

The two have swapped places 4 times across 10 shared years of data; in 2011 it was Sao Tome and Principe ahead.

Eastern Mediterranean (WHO region) ranks 4th and Sao Tome and Principe ranks 1st of 11 groups.

Across the 2 decades both report, Eastern Mediterranean (WHO region) averaged higher in 1 and Sao Tome and Principe in 1.

Head to head by decade

Decade Eastern Mediterranean (WHO region) Sao Tome and Principe Difference Ahead
2010s 66.9% 77.6% 10.7% Sao Tome and Principe
2020s 74.0% 55.7% 18.3% Eastern Mediterranean (WHO region)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate for patients treated for mdr-tb, Eastern Mediterranean (WHO region) or Sao Tome and Principe?
Sao Tome and Principe, at 100.0% against 75.0% in Eastern Mediterranean (WHO region) as of 2022.
What is the difference in treatment success rate for patients treated for mdr-tb between Eastern Mediterranean (WHO region) and Sao Tome and Principe?
25.0%, with Sao Tome and Principe ahead.
How many years of comparable data are there for Eastern Mediterranean (WHO region) and Sao Tome and Principe?
10 years are reported by both, from 2011 to 2022.
How do Eastern Mediterranean (WHO region) and Sao Tome and Principe rank globally for treatment success rate for patients treated for mdr-tb?
Eastern Mediterranean (WHO region) ranks 4th and Sao Tome and Principe ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Eastern Mediterranean (WHO region) vs Sao Tome and Principe: Treatment success rate for patients treated for MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/eastern-mediterranean-who-region/sao-tome-and-principe/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/eastern-mediterranean-who-region/sao-tome-and-principe/">Eastern Mediterranean (WHO region) vs Sao Tome and Principe: Treatment success rate for patients treated for MDR-TB</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed